Harman Finochem Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HARMAN FINOCHEM, and what generic and branded alternatives to HARMAN FINOCHEM drugs are available?
HARMAN FINOCHEM has four approved drugs.
Drugs and US Patents for Harman Finochem
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Harman Finochem | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET;ORAL | 213320-003 | Dec 3, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Harman Finochem | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET;ORAL | 213320-002 | Dec 3, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Harman Finochem | THEOPHYLLINE | theophylline | TABLET, EXTENDED RELEASE;ORAL | 214806-001 | Oct 24, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.